Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mariacarmela Solmone"'
Autor:
Simone Lanini, Anna Rosa Garbuglia, Vincenzo Puro, Mariacarmela Solmone, Lorena Martini, William Arcese, Alessandro Nanni Costa, Piero Borgia, Pierluca Piselli, Maria Rosaria Capobionchi, Giuseppe Ippolito
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33122 (2012)
IntroductionIn western countries the transmission of hepatitis B virus (HBV) transmission through multi-patients lancing devices has been inferred since early '90s, however no study has ever provided biological evidence which directly link these devi
Externí odkaz:
https://doaj.org/article/beb5c4d0812f4bb6aa5b4c9e276748cd
Autor:
Mariacarmela Solmone, Ubaldo Visco Comandini, Gabriella Rozera, Paola Zaccaro, Emanuela Giombini, Maria Rosaria Capobianchi, Barbara Bartolini, Giuseppe Ippolito, Isabella Abbate, Marina Selleri
Publikováno v:
Virus Research. 177:205-208
HCV quasispecies variability represents the background for the selection of mutations and for the development of drug resistance. Natural aminoacid changes in NS3, associated with reduced protease inhibitor susceptibility, have been observed in treat
Autor:
Maria Rosaria Capobianchi, Emanuela Giombini, Isabella Abbate, Manuela Catalano, Mariacarmela Solmone, Angela Testa, Stefano Menzo, Alessandra Moscetti, Gabriella Rozera, Donatella Vincenti
Publikováno v:
Antiviral Therapy. 19:201-209
Background Entecavir is the drug of choice as first-line treatment for treatment-naive HBV patients. As a result of the high genetic barrier to resistance, treatment failure remains rare, but occurs within 3 years of initiation, suggesting that viral
Autor:
Donatella Vincenti, Stefano Menzo, Mariacarmela Solmone, Pierluca Piselli, Gianpiero D'Offizi, Maria Rosaria Capobianchi
Publikováno v:
Antiviral research. 143
Antiviral therapy has revolutionized treatment of chronic HBV infections. First generation compounds, lamivudine and adefovir, displayed a high rate of treatment failures, and have been replaced by more potent compounds with high genetic barrier to r
Autor:
Anna Rosa Garbuglia, Mariacarmela Solmone, Fabio Iacomi, Maria Rosaria Capobianchi, Donatella Vincenti
Publikováno v:
Journal of Virological Methods. 159:53-57
Drug resistance is a crucial problem emerging frequently during treatment of hepatitis B, resulting in treatment failure and progression of liver damage. A direct sequencing method based on a nested PCR was established to detect mutations in samples
Autor:
Giorgio Antonucci, Fabio Iacomi, Maria Rosaria Capobianchi, Donatella Vincenti, Francesco Vairo, Andrea Mariano, Pierluca Piselli, Vincenzo Puro, Mariacarmela Solmone
Publikováno v:
Journal of Medical Virology. 81:1151-1156
A retrospective review was performed comparing lamivudine-resistance mutation patterns between patients infected with hepatitis B virus (HBV) with or without human immunodeficiency virus (HIV) co-infection. Medical records that included a genotypic t
Autor:
Isabella Abbate, M. Paterno, Maria Rosaria Capobianchi, E. Bennici, S. Neri, C. Brega, S. Selvaggini, Mariacarmela Solmone, S. Zaniratti, Niklas Finnstrom
Publikováno v:
Journal of Virological Methods. 151:61-65
CMV viral load quantitation is a powerful tool to assist clinicians in making accurate diagnoses, managing post-transplant CMV disease and monitoring antiviral therapy. The aim of this study was to evaluate the performance of Affigene ® CMV Trender
Autor:
Vincenzo Puro, Fabio Iacomi, Evangelo Boumis, Mariacarmela Solmone, Pierluca Piselli, Francesco Nicola Lauria, Giuseppe Ippolito, Giorgio Antonucci, Maria Rosaria Capobianchi, Ubaldo Visco Comandini, Francesco Vairo
Publikováno v:
Scandinavian Journal of Infectious Diseases. 40:928-934
The role of hepatitis B virus (HBV) or hepatitis D virus (HDV) coinfections as determinants of hepatitis C virus (HCV) suppression in the setting of HIV-HCV coinfection are poorly understood. Our aim was to assess whether HCV viral replication may be
Autor:
Marina Pisciotta, Maria Rosaria Capobianchi, Anna Rosa Garbuglia, Claudio Angeletti, Mariacarmela Solmone, A.M. Cocca, Paola Zaccaro, Francesco Nicola Lauria
Publikováno v:
Journal of Virological Methods. 146:274-280
We compared two commercial assays for HBV DNA quantitation, Versant HBV 3.0, System 340 (bDNA; Bayer Diagnostics) and COBAS AmpliPrep-COBAS TaqMan HBV Test (TaqMan; Roche Diagnostics). Analytical sensitivity, calculated on WHO International Standard,
Autor:
Claudio Angeletti, Giuseppe Ippolito, Maria Rosaria Capobianchi, P Vanacore, Enrico Girardi, Mariacarmela Solmone, Francesco Costa
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 41:361-364
Objective: The aim of the study was to analyze the trends in HIV prevalence among childbearing women through unlinked anonymous testing of newborns. Methods: Dried-blood specimens, residual to routine metabolic screening of newborns, were collected i